ScreenerHero

MTNB Matinas BioPharma Holdings, Inc.

AMEX · US · Healthcare · Biotechnology · matinasbiopharma.com
2.770USD-7.97%Mkt Cap: 2.71M $P/E: —

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology p…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap2.71M USD
Enterprise Value2.19M USD
Revenue (TTM)—
Gross Profit0 USD
Net Income (TTM)-10.35M USD
Revenue/Share—
Last Price2.770 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.00
PEG—
EV/EBITDA-0.33
EV/Revenue—
P/S—
P/B10.71
EPS (TTM)-17.55
EPS (Forward)-3.00
52W Range
2.2652% of range29.85
52W High29.85 USD
52W Low2.265 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-214.18%
ROA-143.52%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.01M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-90.24%
Net Debt-755.00K USD
Net Debt/EBITDA0.11
Balance Sheet
Debt/Equity0.28
Current Ratio0.85
Quick Ratio0.56
Book Value/Sh0.28 USD
Cash/Share0.78 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateSep 28, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.979.52K
Float763.08K
Insiders—
Institutions—
Short Interest
Short Ratio0.3d
Short % Float3.00%
Short % Out.3.00%
Shares Short29.40K
Short (prev mo.)14.93K
Technical
SMA 503.168 (-12.6%)
SMA 2007.706 (-64.1%)
Beta2.08
S&P 52W Chg15.77%
Avg Vol (30d)122.62K
Avg Vol (10d)205.27K
Technical Indicators
RSI (14)46.2
MACD-0.2231
MACD Signal-0.3481
MACD Hist.+0.1250
BB Upper3.071 USD
BB Middle2.657 USD
BB Lower2.242 USD
BB Width31.19%
ATR (14)0.4012 USD
Vol Ratio (20d)1.27x